Advertisement
Advertisement

LFST

LFST logo

LifeStance Health Group, Inc. Common Stock

7.18
USD
Sponsored
+0.11
+1.63%
Feb 02, 15:57 UTC -5
Closed
exchange

After-Market

7.32

+0.13
+1.81%

LFST Earnings Reports

Positive Surprise Ratio

LFST beat 10 of 18 last estimates.

56%

Next Report

Date of Next Report
Mar 05, 2026
Estimate for Q4 25 (Revenue/ EPS)
$383.83M
/
$0.00
Implied change from Q3 25 (Revenue/ EPS)
+5.50%
/
--
Implied change from Q4 24 (Revenue/ EPS)
+17.93%
/
-100.00%

LifeStance Health Group, Inc. Common Stock earnings per share and revenue

On Nov 06, 2025, LFST reported earnings of 0.00 USD per share (EPS) for Q3 25, beating the estimate of -0.01 USD, resulting in a 100.00% surprise. Revenue reached 363.81 million, compared to an expected 362.72 million, with a 0.30% difference. The market reacted with a +29.94% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 analysts forecast an EPS of 0.00 USD, with revenue projected to reach 383.83 million USD, implying an increase of 0.00% EPS, and increase of 5.50% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
DaVita Inc.
Report Date
Feb 02, 2026 For Q4 25
Estimate
$3.18
Actual
$3.40
Surprise
+6.68%
FAQ
For Q3 2025, LifeStance Health Group, Inc. Common Stock reported EPS of $0.00, beating estimates by 100%, and revenue of $363.81M, 0.3% above expectations.
The stock price moved up 29.94%, changed from $4.81 before the earnings release to $6.25 the day after.
The next earning report is scheduled for Mar 05, 2026.
Based on 11 analysts, LifeStance Health Group, Inc. Common Stock is expected to report EPS of -- and revenue of $383.83M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement